CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clindamycin Phosphate And Benzoyl Peroxide, and what generic alternatives are available?
Clindamycin Phosphate And Benzoyl Peroxide is a drug marketed by Actavis Labs Ut Inc, Chartwell Rx, Encube, Glenmark Speclt, Mylan Pharms Inc, Padagis Israel, Taro, and Zydus Pharms. and is included in sixteen NDAs.
The generic ingredient in CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is benzoyl peroxide; clindamycin phosphate. There are seventeen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; clindamycin phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE?
- What are the global sales for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE?
- What is Average Wholesale Price for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE?
Summary for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 13 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Clinical Trials: | 12 |
Patent Applications: | 7 |
What excipients (inactive ingredients) are in CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE? | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE excipients list |
DailyMed Link: | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE at DailyMed |
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Valeant Pharmaceuticals International, Inc. | Phase 2 |
Bausch Health Americas, Inc. | Phase 2 |
Icahn School of Medicine at Mount Sinai | Phase 2 |
See all CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE clinical trials
Pharmacology for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Drug Class | Lincosamide Antibacterial |
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
PATENT CHALLENGE
Exclusivity Expiration: ⤷ Sign Up